Eyup Akgün

1.2k total citations
58 papers, 963 citations indexed

About

Eyup Akgün is a scholar working on Molecular Biology, Organic Chemistry and Cellular and Molecular Neuroscience. According to data from OpenAlex, Eyup Akgün has authored 58 papers receiving a total of 963 indexed citations (citations by other indexed papers that have themselves been cited), including 26 papers in Molecular Biology, 24 papers in Organic Chemistry and 23 papers in Cellular and Molecular Neuroscience. Recurrent topics in Eyup Akgün's work include Neuropeptides and Animal Physiology (21 papers), Pain Mechanisms and Treatments (14 papers) and Pharmacological Receptor Mechanisms and Effects (11 papers). Eyup Akgün is often cited by papers focused on Neuropeptides and Animal Physiology (21 papers), Pain Mechanisms and Treatments (14 papers) and Pharmacological Receptor Mechanisms and Effects (11 papers). Eyup Akgün collaborates with scholars based in United States, Germany and Türkiye. Eyup Akgün's co-authors include Philip S. Portoghese, Mary M. Lunzer, U. PINDUR, Alvin J. Beitz, Branden A. Smeester, Ulf Pindur, Mehmet Tümer, Gunda I. Georg, Chester A. Mathis and Kaleeckal G. Harikumar and has published in prestigious journals such as Proceedings of the National Academy of Sciences, Journal of Biological Chemistry and Blood.

In The Last Decade

Eyup Akgün

56 papers receiving 948 citations

Peers

Eyup Akgün
David J. Wustrow United States
Alex Cordi France
Sigurd Elz Germany
Martyn C. Pritchard United Kingdom
Kevin J. Merchant United States
Eyup Akgün
Citations per year, relative to Eyup Akgün Eyup Akgün (= 1×) peers Serge Turcaud

Countries citing papers authored by Eyup Akgün

Since Specialization
Citations

This map shows the geographic impact of Eyup Akgün's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Eyup Akgün with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Eyup Akgün more than expected).

Fields of papers citing papers by Eyup Akgün

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Eyup Akgün. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Eyup Akgün. The network helps show where Eyup Akgün may publish in the future.

Co-authorship network of co-authors of Eyup Akgün

This figure shows the co-authorship network connecting the top 25 collaborators of Eyup Akgün. A scholar is included among the top collaborators of Eyup Akgün based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Eyup Akgün. Eyup Akgün is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
3.
Akgün, Eyup, et al.. (2024). Synthesis, structural characterization, electrochemical, photophysical and DNA binding properties of two Anderson POM-based hybrids. Journal of Molecular Structure. 1319. 139560–139560. 2 indexed citations
4.
Akgün, Eyup, Muhammet Köse, & Mehmet Tümer. (2024). Supramolecular assembled Keggin based porous material: Synthesis, crystal structure, electrochemical and spectroscopic properties. Inorganic Chemistry Communications. 167. 112818–112818. 1 indexed citations
5.
Lunzer, Mary M., et al.. (2023). MMG22 Potently Blocks Hyperalgesia in Cisplatin-treated Mice. Neuroscience. 516. 54–61. 4 indexed citations
6.
Akgün, Eyup, Mary M. Lunzer, Defeng Tian, et al.. (2020). FBNTI, a DOR-Selective Antagonist That Allosterically Activates MOR within a MOR–DOR Heteromer. Biochemistry. 60(18). 1413–1419. 6 indexed citations
7.
Lunzer, Mary M., et al.. (2019). Targeting MOR-mGluR5 heteromers reduces bone cancer pain by activating MOR and inhibiting mGluR5. Neuropharmacology. 160. 107690–107690. 14 indexed citations
8.
Lunzer, Mary M., et al.. (2019). The bivalent ligand MCC22 potently attenuates hyperalgesia in a mouse model of cisplatin-evoked neuropathic pain without tolerance or reward. Neuropharmacology. 158. 107598–107598. 16 indexed citations
9.
Akgün, Eyup, Mary M. Lunzer, & Philip S. Portoghese. (2018). Combined Glia Inhibition and Opioid Receptor Agonism Afford Highly Potent Analgesics without Tolerance. ACS Chemical Neuroscience. 10(4). 2004–2011. 13 indexed citations
10.
Dutta, Raini, Mary M. Lunzer, Jennifer L. Auger, et al.. (2018). A bivalent compound targeting CCR5 and the mu opioid receptor treats inflammatory arthritis pain in mice without inducing pharmacologic tolerance. Arthritis Research & Therapy. 20(1). 154–154. 26 indexed citations
11.
Smeester, Branden A., Mary M. Lunzer, Eyup Akgün, Alvin J. Beitz, & Philip S. Portoghese. (2014). Targeting putative mu opioid/metabotropic glutamate receptor-5 heteromers produces potent antinociception in a chronic murine bone cancer model. European Journal of Pharmacology. 743. 48–52. 39 indexed citations
12.
Köse, Muhammet, et al.. (2014). A novel Schiff base: Synthesis, structural characterisation and comparative sensor studies for metal ion detections. Spectrochimica Acta Part A Molecular and Biomolecular Spectroscopy. 136. 1388–1394. 20 indexed citations
13.
Akgün, Eyup, et al.. (2013). Ligands that interact with putative MOR-mGluR5 heteromer in mice with inflammatory pain produce potent antinociception. Proceedings of the National Academy of Sciences. 110(28). 11595–11599. 77 indexed citations
14.
Aceto, Mario D., Louis S. Harris, S. Stevens Negus, et al.. (2012). MDAN-21: A Bivalent Opioid Ligand Containing mu-Agonist and Delta-Antagonist Pharmacophores and Its Effects in Rhesus Monkeys. PubMed. 2012. 1–6. 27 indexed citations
15.
Cawston, Erin E., Polo C.‐H. Lam, Kaleeckal G. Harikumar, et al.. (2012). Molecular Basis for Binding and Subtype Selectivity of 1,4-Benzodiazepine Antagonist Ligands of the Cholecystokinin Receptor. Journal of Biological Chemistry. 287(22). 18618–18635. 20 indexed citations
16.
Harikumar, Kaleeckal G., Eyup Akgün, Philip S. Portoghese, & Laurence J. Miller. (2010). Modulation of Cell Surface Expression of Nonactivated Cholecystokinin Receptors Using Bivalent Ligand-Induced Internalization. Journal of Medicinal Chemistry. 53(7). 2836–2842. 15 indexed citations
17.
Akgün, Eyup, et al.. (1989). A novel synthesis of 2‐vinylindoles and their utilization in the diels‐alder reaction for the formation of new [c] annellated carbazole derivatives. Journal of Heterocyclic Chemistry. 26(6). 1869–1873. 5 indexed citations
18.
Akgün, Eyup, Mustafa Tunalı, & Ulf Pindur. (1987). The Reactions of Electron‐Rich Heterocycles with Derivatives of Orthocarboxylic Acids; VIII. Proton Acid‐Catalyzed Acylation of Indoles by 2‐Alkoxy‐1,3‐dioxolanes. Archiv der Pharmazie. 320(5). 397–401. 11 indexed citations
20.
Akgün, Eyup & U. PINDUR. (1985). Chemische eigenschaften und synthese‐verfahren von 3‐vinylindolen. Journal of Heterocyclic Chemistry. 22(3). 585–591. 22 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026